Rarecells

Rarecells, Inc. is a healthcare company dedicated to the development and commercialization of non-invasive early cancer detection tests. These tests are based on the ISET® platform technology, capable of extracting blood cancer cells from any type of cancer. The cancer cells extracted by ISET® are then diagnostically identified through immunomorphological molecular analysis combined with image analysis and AI.